SkinAware
SkinAware

Medication or Therapy for Skin Picking: How to Choose

Aug 3, 2026·10 min read

Behavioral treatment has the stronger evidence for skin picking. The five situations where medication should go first, and why access usually decides.

Written using peer-reviewed research including Schumer, Bartley & Bloch (2016) in the Journal of Clinical Psychopharmacology, Modanlo, Yan & Bourgeois (2025) in the Journal of the Academy of Consultation-Liaison Psychiatry, Grant & Chamberlain (2022) in Comprehensive Psychiatry, and a 2024 randomized trial in Behavior Therapy, alongside clinical guidance from the TLC Foundation for BFRBs and the Merck Manual.

Start with behavioral treatment. It has the stronger evidence, it carries no side effects, and it is the only approach that has beaten an inactive control in a pooled analysis of skin picking trials. Medication goes first under a specific set of conditions, and one of those conditions is that behavioral treatment is not actually reachable, which for a lot of people it isn't.

That last part is why this decision is rarely as clean as the research makes it sound.

0.69 vs 0.21pooled effect vs controls: behavioral treatment vs SSRIs
0medications approved for skin picking disorder
87%of 262 assessed adults had never had any treatment

The comparison, on one screen

Behavioral treatment (HRT / CBT / ComB)Medication (SSRI, NAC, memantine)
Best pooled evidence vs inactive controls0.69, statistically significant (3 randomized trials)SSRIs: 0.21, not significant (2 randomized trials, 62 people)
Approved for skin pickingNot a licensing questionNone. Every drug used is off-label
Time before you can judge it4 to 10 weeks12 weeks for NAC, 8 to 12 for an SSRI
Typical cost$100 to $250 a session, $800 to $4,000 a coursePrescriber visits plus the prescription; NAC is bought over the counter
Main obstacleFinding someone trained in itNothing is approved, and the effect on picking is modest
Treats co-occurring depression or anxietyIndirectly at bestYes, and this is where the drug evidence is strongest
Can be self-directedYes, imperfectlyNo
What it asks of youDaily practice for monthsTaking a pill and reporting back

Two rows carry most of the weight. The first, because it is the closest thing to a direct comparison that exists. And the last, because one real reason medication appeals is that the other column is asking for something harder.

What the comparative evidence shows

One analysis has put both treatments through the same statistical machinery on the same page, and it is why "behavioral first" is the standard answer.

Two things complicate that finding, and between them they explain why one page tells you SSRIs are the most effective option and the next tells you they do nothing.

Nobody has run the head-to-head trial. No published study has randomized people with skin picking to a course of therapy against a course of medication and compared the arms. The reviews collecting this literature contain drug-versus-placebo trials and behavior-versus-waitlist trials. The comparison between them is arithmetic performed afterwards on separate studies with different participants, different lengths and different outcome measures. It is the best evidence available and it is not the same thing as a race.

A balance scale holding a tall stack of behavioral therapy notebooks on one side and a much shorter stack of medication trial papers on the other, with an empty tray between them where a direct comparison would sit
Two separate piles of evidence, weighed against placebo rather than against each other. The tray in the middle is still empty.

And the medication reviews rank medications against each other, not against therapy. A 2025 review in the Journal of the Academy of Consultation-Liaison Psychiatry screened two decades of research, kept 13 studies covering 289 patients, and concluded that SSRIs "show the most promising results in terms of mitigating the severity and frequency of skin-picking symptoms." That review looked only at drugs.

Clinicians disagree about the within-category ranking too, which is worth knowing before you assume a single right answer exists. The Merck Manual's professional edition describes N-acetylcysteine and memantine as increasingly considered the first-line medication treatment. Teaching material aimed at prescribers still puts SSRIs first, reasoning that skin picking sits in the obsessive-compulsive family and should be dosed like it. Both positions are held by people who treat this for a living. If you want the underlying trials rather than the summary, the SSRI evidence for skin picking and the NAC evidence each get a page of their own.

Five situations where medication goes first

"Behavioral first" is a statement about populations. It is not a rule about you. These are the circumstances where starting with a prescription is the better call, and none of them is a compromise.

1. Depression or anxiety is doing the driving. The strongest case, and not really a case about picking at all. Depression, generalized anxiety, OCD and ADHD are all common alongside skin picking, and those conditions have large, well-replicated drug evidence behind them in a way picking itself does not. If getting out of bed is the problem, a competing-response drill is not this month's intervention. Depression alongside picking is worth treating for its own sake, and anxiety and picking feed each other in both directions.

2. Severity is high enough that you can't engage with anything. Behavioral treatment asks for daily logging, twenty rehearsals of a hand position, and a willingness to look closely at something you feel ashamed of. There is a level of distress at which that is genuinely not available to a person. Lowering the emotional temperature first is a sequence, not a surrender.

3. A real behavioral attempt has already failed. Real means with someone who named a protocol, with self-monitoring from week one, sustained past the point where awareness alone stops helping. A course of general talk therapy with someone who suggested you sit on your hands is not a failed attempt at behavioral treatment. It is never having had it.

4. There's no trained therapist you can reach. The most common reason in practice and the least discussed. Hundreds of US providers have completed the TLC Foundation's professional training program. No other country has more than ten. If the nearest specialist is four hours away and closed to new patients, a prescriber you can see next month is a real option and a waitlist is not. Finding a BFRB therapist covers the directories worth checking before you conclude there isn't one.

5. You're already on an SSRI for something else. Then the question isn't whether to start medication. It's whether the one you're taking is doing anything for the picking, which is far easier to answer with eight weeks of numbers than from memory.

Why almost everyone ends up on both

Combining is the standard clinical position. The TLC Foundation states it plainly: "In most cases, medications appear most helpful when used in combination with ongoing behavior therapy." Cleveland Clinic, WebMD and essentially every consumer page on this topic say a version of the same thing.

Be clear about what that consensus rests on. It's clinical experience and mechanism, not a trial comparing combined treatment against either half alone in skin picking. Nobody has run that study either.

The mechanism argument is still a good one. The two approaches aim at different links in the same chain. Medication, where it works, lowers the pressure behind the urge. Behavioral work changes what your hands do when the urge arrives anyway. A drug that reduces how often urges show up does nothing about a motor pattern that's been running for fifteen years, and a competing response does nothing about the anxiety generating the urges. The habit reversal protocol is the part that handles the second job, and it's learnable whether or not there's a prescription alongside it.

What each path costs, and how fast it starts

This is the section the clinical pages leave out, and for most readers it decides the outcome more than anything above.

Behavioral treatmentMedication
Where you startA BFRB-trained therapist, or a self-directed protocolA GP or psychiatrist
Realistic waitWeeks to months, or never, depending where you liveUsually the shortest route to any treatment at all
Session cost, US private pay$100 to $250 an hour, higher in major citiesThe appointment, then the prescription
Course cost$800 to $4,000 for eight to sixteen sessionsGeneric SSRIs are among the cheapest drugs available; NAC is sold over the counter
InsuranceExcoriation disorder has its own code, F42.4, and parity rules apply. Many BFRB specialists take no insurancePrescriber visits and prescriptions are ordinary covered care
If it worksYou keep the skill without paying againYou keep paying, and gains often fade after stopping
Two doorways side by side, one standing open with a clear path through it and one with a long line of waiting figures, illustrating that access rather than evidence usually decides which treatment a person starts
The evidence points one way. The doors open at very different speeds.

That last row is the one people underweight. A competing response you've rehearsed for six months belongs to you. A medication effect belongs to the medication.

The row above it is why the evidence-based answer and the practical answer come apart. Getting an SSRI prescribed is, for most people in most countries, the shortest path to being treated for anything. Getting eight weekly appointments with someone who has actually run a picking protocol is, for many people, not a path that exists. In a study of 262 adults with skin picking disorder assessed in person, 87% had never received any treatment for it. That figure isn't made of people who weighed the evidence and chose badly. What a course of CBT for skin picking actually involves covers the costs, the billing codes and the questions that sort specialists from generalists.

If neither is reachable right now

For a large share of readers this is the real section.

Self-directed behavioral work is a genuine option rather than a consolation prize, and the reason isn't encouragement, it's trial design.

The active ingredients survive being delivered at a distance. Three things decide whether a self-directed attempt holds.

A log that outlives week one. Every session of the published CBT protocol assigns self-monitoring, from the first week to the last. If you build nothing else, build that. It's also what turns a future appointment from a guessing session into a data review.

Structure past the awareness stage. The failure mode of doing this alone is finishing the awareness component, feeling noticeably better, and stopping. Awareness alone buys a fortnight.

One person who knows. Social support is a formal component of the protocol and the first thing cut from self-help versions of it.

SkinAware covers those three directly. The habit reversal course runs as four modules, from the habit loop and the two kinds of episode through trigger mapping, competing responses and long-term maintenance. Episode and urge logging is the self-monitoring task in a form you'll actually open at eleven at night, and it tracks urges you resisted as well as episodes, which is usually where the first change shows up. Accountability friends and a moderated community cover the support component when there's nobody in the house to brief. It costs $5.99 a month or $34.99 a year, which is a useful reference point against the therapy column above, and it isn't a substitute for a trained therapist where one is available.

If you're weighing the alternatives first, we've compared the apps in this space, including several that cost more per month than a therapy session.

Start the part you can start today

Log episodes and resisted urges in seconds, and work through the habit reversal course while you decide about the rest.

Frequently asked questions

Behavioral treatment has the better evidence. In the one analysis that pooled both, behavioral treatments beat inactive controls with a standardized mean difference of 0.69, while SSRIs across two randomized trials came in at 0.21 and were not significantly different from placebo. No trial has compared the two directly, so this is a comparison across separate studies rather than a head-to-head result.

Behavioral treatment first, unless one of five things is true: co-occurring depression or anxiety needs treating in its own right, severity is high enough that you can't engage with daily practice, a genuine protocol-based behavioral attempt has already failed, no trained therapist is reachable, or you're already on an SSRI and want to know whether it's helping the picking.

Unlikely on its own. No drug is approved for skin picking, every prescription is off-label, and the improvement reported in the drug literature is modest and often doesn't outlast stopping. Medication is generally described as lowering the pressure behind urges rather than changing what your hands do when one arrives.

No. Behavioral treatment is a standalone treatment with its own evidence base, and plenty of people are treated with it alone. Medication is a separate decision with a separate prescriber.

They're answering different questions. Reviews of medications rank medications against each other, and within that set SSRIs come out ahead. Analyses that compare against placebo find the two randomized SSRI trials in skin picking didn't separate from a dummy pill. Both statements describe the same small evidence base.

It isn't presented that way by the people who studied it. The researcher behind the main skin picking trial recommends that anyone taking NAC also be doing behavior therapy. It has one positive randomized trial behind it, which is more than the SSRIs have for picking specifically and much less than the behavioral literature.

Ask what model that therapist used. Generic talk therapy is a different intervention from a BFRB protocol, and a failed course with a generalist says very little about whether protocol-based treatment would work for you.

Yes, and most treatment plans do. Staggering the start dates by four to six weeks makes it possible to tell later which one is earning its place, which matters if you'd rather not stay on a medication indefinitely without knowing what it's doing.


References

  • Schumer, M. C., Bartley, C. A., & Bloch, M. H. (2016). Systematic review of pharmacological and behavioral treatments for skin picking disorder. Journal of Clinical Psychopharmacology, 36(2), 147–152.
  • Modanlo, N., Yan, X., & Bourgeois, J. A. (2025). Pharmacologic management of skin-picking disorder: An updated review. Journal of the Academy of Consultation-Liaison Psychiatry, 66(5), 417–428.
  • Grant, J. E., & Chamberlain, S. R. (2022). Characteristics of 262 adults with skin picking disorder. Comprehensive Psychiatry, 117, 152338.
  • Selles, R. R., McGuire, J. F., Small, B. J., & Storch, E. A. (2016). A systematic review and meta-analysis of psychiatric treatments for excoriation (skin-picking) disorder. General Hospital Psychiatry, 41, 29–37.
  • Behavior Therapy (2024). Therapist-guided internet-delivered acceptance-enhanced behavior therapy for skin picking disorder: a randomized controlled trial.
  • The TLC Foundation for BFRBs. Medications for Body-Focused Repetitive Behaviors. Updated June 2025.
  • Merck Manual Professional Edition. Excoriation (Skin-Picking) Disorder. Retrieved July 2026.
  • Skin Picking Support. International Help for Skin Picking, Hair Pulling and other BFRBs. Retrieved July 2026.

Last updated: July 2026